Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOT109 in Advanced Colorectal Cancer
NCT07693751Phase 2Recruiting
- Sponsor
- SOTIO Biotech
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 2
01
Overview
A Phase 2 trial of SOT109 in colorectal cancer (CRC), sponsored by SOTIO Biotech. Started Aug 2026; status: recruiting.
02
Drugs
SOT109
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07693751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693751.